¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹°£´ãÃé¿Ü°úÇÐȸ Á¦13Â÷ ±¹Á¦½Ì±ÛÅäÇȽÉÆ÷Áö¿ò : 2018-09-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Çѱ¹°£´ãÃé¿Ü°úÇÐȸ Á¦13Â÷ ±¹Á¦½Ì±ÛÅäÇȽÉÆ÷Áö¿ò : 2018-09-14
±³À°ÀÏÀÚ : 2018-09-14
±³À°Àå¼Ò : ¿©¼ö ¿¥ºíÈ£ÅÚ 1Ãþ ±×·£µåº¼·ë  
±³À°ÁÖÁ¦ : Á¦13Â÷ ±¹Á¦½Ì±ÛÅäÇȽÉÆ÷Áö¿ò      
ÁÖÃÖ±â°ü : Çѱ¹°£´ãÃé¿Ü°úÇÐȸ
´ã´çÀÚ : À̺¸¹Ì
¿¬¶ôó : 02-2227-8299  
À̸ÞÀÏ : khbps@khbp.or.kr      
±³À°Á¾·ù : ¿Ü°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : Àü¶ó³²µµ
±³À°½Ã°£ : 4 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í [Æò»ýȸ¿ø,Á¤È¸¿ø] »çÀüµî·Ï: 50,000¿ø / ÇöÀåµî·Ï 70,000¿ø [Àü°øÀÇ, °£È£»ç, ±ºÀÇ°ü] »çÀüµî·Ï: 30,000¿ø / ÇöÀåµî·Ï 50,000¿ø [ºñȸ¿ø] »çÀüµî·Ï: 70,000¿ø / ÇöÀåµî·Ï: 100,000¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 12:40~12:50 Introduction: Posthepatectomy Liver Failure (PHLF)  ¹Ú»óÀç(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 12:50~13:10 Various factors associated with liver regeneration after hepatectomy  ±è¼¼ÁØ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 13:10~13:30 Quantified risk assessment of PHLF in cirrhotic liver  Á¤µ¿È¯(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 13:30~13:50 Impact and prediction of chemotherapy-associated liver injury  ÇÑ´ëÈÆ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 13:50~14:10 Risk prediction of PHLF in patients with perihilar cholangiocarcinoma  ÃÖ»õº°(°í·ÁÀÇ´ë) 
Åä·Ð 09¿ù 14ÀÏ ±×·£µåº¼·ë 14:10~14:20 Discussion  () 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 14:20~14:50 Virtual and augmented reality for image-guided surgery  Maki Sugimoto(International University of Health and Welfare) 
È޽Ġ09¿ù 14ÀÏ ±×·£µåº¼·ë 14:50~15:10 Coffee Break  () 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 15:10~15:30 Knack and pitfall of various PVE techniques  °í±â¿µ(¿ï»êÀÇ´ë ¿µ»óÀÇÇаú) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 15:30~15:50 Outcome and safety of PVE between cirrhotic, cholestatic, and normal liver  ¾È±Ù¼ö(°è¸íÀÇ´ë) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 15:50~16:05 What next when PVE fails to induce enough hypertrophy?  ÀÓâ¼·(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 16:05~16:20 Drawback of PVE: oncologic perspectives  ÃÖ¿µ·Ï(ºÐ´ç¼­¿ï´ë) 
Åä·Ð 09¿ù 14ÀÏ ±×·£µåº¼·ë 16:20~16:30 Discussion  () 
È޽Ġ09¿ù 14ÀÏ ±×·£µåº¼·ë 16:30~16:40 Break  () 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 16:40~16:55 Indication of PBD with regard to background liver, FLR and patient¡¯s condition  ±èÈñÁØ(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 16:55~17:10 Optimal preoperative bilirubin level with regard to background liver, FLR and patient¡¯s condition  ¼­ÇüÀÏ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 17:10~17:25 Endoscopic biliary drainage: is it oncologically safe?  ±è¿ëÈÆ(°è¸íÀÇ´ë) 
±³À°½Ã°£ 09¿ù 14ÀÏ ±×·£µåº¼·ë 17:25~17:40 Simultaneous PVE and PBD; is it feasible?  È«ÅÂÈ£(°¡Å縯ÀÇ´ë) 
Åä·Ð 09¿ù 14ÀÏ ±×·£µåº¼·ë 17:40~17:50 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹°£´ãÃé¿Ü°úÇÐȸ Á¦13Â÷ ±¹Á¦½Ì±ÛÅäÇȽÉÆ÷Áö¿ò : 2018-09-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ±¹¸³¾Ï¼¾ÅÍ ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ǹ®´õ½Ê°úÁ¤ : 2018-09-15
´ÙÀ½±Û ºÎ»ê¼Ò¾Æ°úÇÐȸ Á¤±â Çмú Áý´äȸ : 2018-09-13
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
279 °­¿ø ÇѸ²´ëÇб³Ãáõ¼º½Éº´¿ø Á¦ 130ȸ ¼ÒÈ­±â¼¾ÅÍ ¿¬¼ö±³À° : 2018-09-19 0 734 2018-07-28
278 ¼­¿ï Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ Á¤±âÇмú´ëȸ : 2018-09-19 0 502 2018-07-28
277 ¼­¿ï ¼ÛÆı¸(4Â÷) °³¿øÀÇ ¿¬¼ö±³À°(¿äÅëȯÀÚ, °ñ´Ù°øÁõ) : 2018-09-18 0 506 2018-07-28
276 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ¾È°úÁö¿ªÀÇ»ç Áý´ãȸ : 2018-09-18 0 519 2018-07-28
275 °æ±â Â÷ÀÇ°úÇдëÇб³ºÐ´çÂ÷º´¿ø ³ì³»Àå : 2018-09-18 0 658 2018-07-28
274 ´ë±¸ ´ëÇѽŰæ°úÇÐȸ ´ë°æÁöȸ - ´ë°æ½Å°æ°úÀÇ»çȸ °øµ¿ ½ÉÆ÷Áö¿ò : 2018-09-18 0 1,497 2018-07-28
273 ¼­¿ï Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ Á¤±âÇмú´ëȸ : 2018-09-18 0 619 2018-07-28
272 ¼­¿ï Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ Á¤±âÇмú´ëȸ : 2018-09-17 0 425 2018-07-28
271 °æ±â Á¦ 1ȸ ¾ÆÁִ뺴¿ø ½ÅÀå³»°ú ¿¬¼ö°­Á : 2018-09-16 0 2,092 2018-07-28
270 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Á¦53Â÷ ¾Ë·¹¸£±â ±³À°°­Á : 2018-09-16 0 568 2018-07-28
269 ¼­¿ï 2018³â Á¦3ȸ »ï¼º¼­¿ïº´¿ø ¿Ü°ú ½ÉÆ÷Áö¿ò : 2018-09-16 0 932 2018-07-28
268 ´ë±¸ 2018³âµµ ´ëÇÑÁ¤Çü¿Ü°úÀÇ»çȸ Çмú´ëȸ : 2018-09-16 0 821 2018-07-28
267 ¼­¿ï ½ÉÀå´ë»çÁõÈıº¿¬±¸È¸ 2018 Ãß°è½ÉÆ÷Áö¾ö : 2018-09-15 0 676 2018-07-28
266 ¼­¿ï °æÈñ´ëÇб³º´¿ø µ¿¹®Áý´ãȸ_°íȲÀ̺ñÀÎÈÄ°ú ¿¬±¸È¸ ¼¼¹Ì³ª : 2018-09-15 0 1,393 2018-07-28
265 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : °æ°è¼± ÀΰÝÀå¾Ö : 2018-09-15 0 1,170 2018-07-28
1361 | 1362 | 1363 | 1364 | 1365 | 1366 | 1367 | 1368 | 1369 | 1370
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷